vs
艾利丹尼森（AVY）与Ventas（VTR）财务数据对比。点击上方公司名可切换其他公司
艾利丹尼森的季度营收约是Ventas的1.4倍（$2.3B vs $1.7B），艾利丹尼森净利率更高（7.3% vs 3.6%，领先3.7%），Ventas同比增速更快（22.0% vs 7.0%），过去两年Ventas的营收复合增速更高（17.5% vs 1.4%）
艾利丹尼森是总部位于美国俄亥俄州门托市的财富500强跨国企业，专业从事压敏胶材料、服装品牌标签吊牌、RFID嵌体及特种医疗产品的生产与分销，业务覆盖全球多个主要市场。
Ventas是一家领先的医疗地产投资信托企业，旗下资产涵盖养老社区、医疗办公楼、生命科学研究设施及康复医疗中心等，主要在北美、英国地区运营，为医疗服务及生命科学机构提供专业物业解决方案。
AVY vs VTR — 直观对比
营收规模更大
AVY
是对方的1.4倍
$1.7B
营收增速更快
VTR
高出15.0%
7.0%
净利率更高
AVY
高出3.7%
3.6%
两年增速更快
VTR
近两年复合增速
1.4%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.3B | $1.7B |
| 净利润 | $168.1M | $59.0M |
| 毛利率 | 28.9% | — |
| 营业利润率 | 10.7% | — |
| 净利率 | 7.3% | 3.6% |
| 营收同比 | 7.0% | 22.0% |
| 净利润同比 | 1.1% | 19.0% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVYVTR
| Q1 26 | $2.3B | $1.7B | ||
| Q4 25 | $2.3B | $1.6B | ||
| Q3 25 | $2.2B | $1.5B | ||
| Q2 25 | $2.2B | $1.4B | ||
| Q1 25 | $2.1B | $1.4B | ||
| Q4 24 | $2.2B | $1.3B | ||
| Q3 24 | $2.2B | $1.2B | ||
| Q2 24 | $2.2B | $1.2B |
净利润AVYVTR
| Q1 26 | $168.1M | $59.0M | ||
| Q4 25 | $166.4M | $73.0M | ||
| Q3 25 | $166.3M | $68.7M | ||
| Q2 25 | $189.0M | $71.5M | ||
| Q1 25 | $166.3M | $48.4M | ||
| Q4 24 | $174.0M | $58.7M | ||
| Q3 24 | $181.7M | $21.0M | ||
| Q2 24 | $176.8M | $21.2M |
毛利率AVYVTR
| Q1 26 | 28.9% | — | ||
| Q4 25 | 28.7% | — | ||
| Q3 25 | 28.7% | — | ||
| Q2 25 | 28.8% | — | ||
| Q1 25 | 28.9% | — | ||
| Q4 24 | 27.9% | — | ||
| Q3 24 | 28.7% | — | ||
| Q2 24 | 29.6% | — |
营业利润率AVYVTR
| Q1 26 | 10.7% | — | ||
| Q4 25 | 9.1% | 4.9% | ||
| Q3 25 | 10.6% | 3.0% | ||
| Q2 25 | 11.5% | 3.0% | ||
| Q1 25 | 10.6% | 3.0% | ||
| Q4 24 | 11.0% | -0.0% | ||
| Q3 24 | 11.0% | 1.5% | ||
| Q2 24 | 10.7% | -1.6% |
净利率AVYVTR
| Q1 26 | 7.3% | 3.6% | ||
| Q4 25 | 7.3% | 4.7% | ||
| Q3 25 | 7.5% | 4.6% | ||
| Q2 25 | 8.5% | 5.0% | ||
| Q1 25 | 7.7% | 3.6% | ||
| Q4 24 | 8.0% | 4.6% | ||
| Q3 24 | 8.3% | 1.7% | ||
| Q2 24 | 7.9% | 1.8% |
每股收益（稀释后）AVYVTR
| Q1 26 | — | — | ||
| Q4 25 | $2.16 | $0.15 | ||
| Q3 25 | $2.13 | $0.14 | ||
| Q2 25 | $2.41 | $0.15 | ||
| Q1 25 | $2.09 | $0.10 | ||
| Q4 24 | $2.17 | $0.13 | ||
| Q3 24 | $2.25 | $0.05 | ||
| Q2 24 | $2.18 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $255.1M | $183.6M |
| 总债务越低越好 | $3.2B | — |
| 股东权益账面价值 | $2.3B | $13.2B |
| 总资产 | $9.0B | $27.7B |
| 负债/权益比越低杠杆越低 | 1.38× | — |
8季度趋势，按日历期对齐
现金及短期投资AVYVTR
| Q1 26 | $255.1M | $183.6M | ||
| Q4 25 | $202.8M | $741.1M | ||
| Q3 25 | $536.3M | $188.6M | ||
| Q2 25 | $215.9M | $614.2M | ||
| Q1 25 | $195.9M | $182.3M | ||
| Q4 24 | $329.1M | $897.9M | ||
| Q3 24 | $212.7M | $1.1B | ||
| Q2 24 | $208.8M | $557.1M |
总债务AVYVTR
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | $13.0B | ||
| Q3 25 | $3.2B | — | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.6B | — | ||
| Q4 24 | $2.6B | $13.5B | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.0B | — |
股东权益AVYVTR
| Q1 26 | $2.3B | $13.2B | ||
| Q4 25 | $2.2B | $12.5B | ||
| Q3 25 | $2.2B | $12.4B | ||
| Q2 25 | $2.2B | $11.5B | ||
| Q1 25 | $2.2B | $11.5B | ||
| Q4 24 | $2.3B | $10.8B | ||
| Q3 24 | $2.4B | $9.8B | ||
| Q2 24 | $2.3B | $9.6B |
总资产AVYVTR
| Q1 26 | $9.0B | $27.7B | ||
| Q4 25 | $8.8B | $27.6B | ||
| Q3 25 | $8.9B | $26.9B | ||
| Q2 25 | $8.6B | $26.5B | ||
| Q1 25 | $8.4B | $26.0B | ||
| Q4 24 | $8.4B | $26.2B | ||
| Q3 24 | $8.5B | $25.3B | ||
| Q2 24 | $8.3B | $24.5B |
负债/权益比AVYVTR
| Q1 26 | 1.38× | — | ||
| Q4 25 | 1.43× | 1.04× | ||
| Q3 25 | 1.45× | — | ||
| Q2 25 | 1.19× | — | ||
| Q1 25 | 1.19× | — | ||
| Q4 24 | 1.11× | 1.26× | ||
| Q3 24 | 0.85× | — | ||
| Q2 24 | 0.89× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | — |
| 自由现金流经营现金流 - 资本支出 | $104.4M | — |
| 自由现金流率自由现金流/营收 | 4.5% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $869.1M | — |
8季度趋势，按日历期对齐
经营现金流AVYVTR
| Q1 26 | — | — | ||
| Q4 25 | $376.8M | $471.7M | ||
| Q3 25 | $312.1M | $378.6M | ||
| Q2 25 | $208.8M | $475.3M | ||
| Q1 25 | $-16.3M | $321.1M | ||
| Q4 24 | $351.2M | $373.6M | ||
| Q3 24 | $270.1M | $353.7M | ||
| Q2 24 | $197.7M | $335.9M |
自由现金流AVYVTR
| Q1 26 | $104.4M | — | ||
| Q4 25 | $309.7M | — | ||
| Q3 25 | $276.2M | — | ||
| Q2 25 | $178.8M | — | ||
| Q1 25 | $-52.3M | — | ||
| Q4 24 | $281.7M | — | ||
| Q3 24 | $227.1M | — | ||
| Q2 24 | $150.2M | — |
自由现金流率AVYVTR
| Q1 26 | 4.5% | — | ||
| Q4 25 | 13.6% | — | ||
| Q3 25 | 12.5% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | -2.4% | — | ||
| Q4 24 | 12.9% | — | ||
| Q3 24 | 10.4% | — | ||
| Q2 24 | 6.7% | — |
资本支出强度AVYVTR
| Q1 26 | — | — | ||
| Q4 25 | 3.0% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 3.2% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.1% | — |
现金转化率AVYVTR
| Q1 26 | — | — | ||
| Q4 25 | 2.26× | 6.46× | ||
| Q3 25 | 1.88× | 5.51× | ||
| Q2 25 | 1.10× | 6.65× | ||
| Q1 25 | -0.10× | 6.64× | ||
| Q4 24 | 2.02× | 6.36× | ||
| Q3 24 | 1.49× | 16.84× | ||
| Q2 24 | 1.12× | 15.87× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVY
| Materials Group | $1.6B | 72% |
| Solutions Group | $649.2M | 28% |
VTR
| Resident fees and services | $1.3B | 78% |
| Outpatient medical and research portfolio | $230.1M | 14% |
| Triple-net leased properties | $123.1M | 7% |
| Third-party capital management revenues | $4.4M | 0% |
